Axonics

Open enrollment across a mixed-phase pipeline

According to ClinicalTrials.gov-derived indexes, Axonics sits in the upper quartile of US sponsors by registered trial count (#1,806 of 15,742 sponsors by registered trial count).

7 total trials 2 currently recruiting 2 completed upper quartile by trial count

Axonics: 7 sponsored US clinical trials, 2 recruiting.

Axonics sponsors 7 registered US clinical trials on ClinicalTrials.gov, 2 of them currently recruiting, and 2 completed. The most-studied condition in this pipeline is Urinary Frequency (UF), with 2 trials.

Upper-quartile sponsor footprint

Axonics sits in the upper quartile of the sponsor corpus (#1,806 of 15,742 sponsors by registered trial count) - denser than most sponsors, still short of the top-decile hubs.

What is open in the Axonics pipeline

2 recruiting of 7 indexed (29% open); 2 completed (29%).

Phase labels are sparse on this sponsor index, so phase mix is not charted here.

Top condition: Urinary Frequency (UF) (2 trials), 9 others listed.

How open-pipeline share is computed

Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.

Axonics: open-pipeline peers nationwide

Peers matched on 7 registered trials and 29% open enrollment, not the therapeutic-area sidebar.

Axonics sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot). 2×2 strategic matrix plotting 9 entities by Total trials (X) and Recruiting share (Y), with a crosshair dividing the plot into four quadrants. Higher volume & more openFocused & more openHigher volume, mostly closedSmaller & mostly closed 0102030405060 0%10%20%30%40% Total trials Recruiting share Axonics3M4Life Research89bioAbbott Diagnostics DivisionAlabama Physical Therapy & AcupunctureAlloSourceAlnylam PharmaceuticalsAnnovis Bio
Axonics sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot).

Axonics sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.

Sponsors near 7 trials (± recruiting share)

Sponsors near 29% open enrollment (± trial volume)

What to do with this Axonics page

7 registered trials is a research-attention snapshot, not an endorsement of Axonics or any single study.

  • 2 of Axonics's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
  • Urinary Frequency (UF) is the condition Axonics studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Urinary Frequency (UF) trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Axonics pipeline card: 7 registered trials from official public datasets.Report a data error.